Related Experiment Video

Updated: Mar 24, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

8.4K

Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity

Edward J Hennessy1

  • 1Oncology iMed, Innovative Medicines & Early Development, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States.

Bioorganic & Medicinal Chemistry Letters
|March 19, 2016
PubMed

Insights

Targeting specific Bcl-2 family proteins, like Bcl-2 or Bcl-xL, offers a new strategy for cancer treatment. This approach aims to improve anticancer drug effectiveness while reducing toxic side effects by selectively inhibiting apoptosis regulators.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Apoptosis induction in tumor cells is a key cancer treatment strategy.
  • Bcl-2 family proteins regulate apoptosis and are targets for anticancer drugs.
  • Current Bcl-2-targeting drugs show efficacy but have toxicities due to broad interactions.

Purpose of the Study:

  • To review the biological rationale for targeting single Bcl-2 family members.
  • To highlight selective Bcl-2 or Bcl-xL inhibitors from recent literature.
  • To discuss the structural basis for selectivity in these novel agents.

Main Methods:

  • Literature review of recent studies on selective Bcl-2 family inhibitors.
  • Analysis of biological rationale for single-target engagement.
  • Examination of structural data for reported compound selectivity.

Main Results:

  • Selective targeting of Bcl-2 or Bcl-xL is a promising strategy for enhanced therapeutic margins.
  • Several novel compounds demonstrating selectivity have been identified.
  • Structural insights are emerging that explain the basis of this selectivity.

Conclusions:

  • Selective Bcl-2 family inhibition represents a refined approach to cancer therapy.
  • Future drug development should focus on achieving high selectivity for improved safety and efficacy.
  • Understanding the structural basis of selectivity is crucial for designing next-generation anticancer agents.
Keywords:
ApoptosisBcl-2 family proteinsProtein–protein interactionsSelectivity

More Related Videos

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

3.2K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
17
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K